NGFR and psychiatric disorder: In addition to the possibility of p75NTR as an early diagnostic biomarker, its role could be extended to disease progression (Shepheard et al., 2017), and also be of interest as a pharmacodynamic biomarker to assess the effect of treatment, which is lacking in multiple neurological and psychiatric diseases (Simmons et al., 2021).